88 related articles for article (PubMed ID: 38167452)
21. A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.
Feng C; Yu A; Wang Z; Wang K; Chen J; Wu Y; Deng T; Chen H; Hou Y; Ma S; Dai X; Huang L
J Exp Clin Cancer Res; 2024 Jan; 43(1):9. PubMed ID: 38167452
[TBL] [Abstract][Full Text] [Related]
22. Sodium thiosulfate inhibits epithelial-mesenchymal transition in melanoma via regulating the Wnt/β-catenin signaling pathway.
Wang D; Li S; Chen Y; Luo J; Li L; Wang B; Xu Y; Liang Y
J Dermatol Sci; 2023 Feb; 109(2):89-98. PubMed ID: 36870927
[TBL] [Abstract][Full Text] [Related]
23. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
24. Podoplanin regulates mammary stem cell function and tumorigenesis by potentiating Wnt/β-catenin signaling.
Bresson L; Faraldo MM; Di-Cicco A; Quintanilla M; Glukhova MA; Deugnier MA
Development; 2018 Feb; 145(4):. PubMed ID: 29361573
[TBL] [Abstract][Full Text] [Related]
25. KLF3 Transcription Activates WNT1 and Promotes the Growth and Metastasis of Gastric Cancer via Activation of the WNT/β-Catenin Signaling Pathway.
Li Y; Wang Y; Zou Q; Li S; Zhang F
Lab Invest; 2023 Jun; 103(6):100078. PubMed ID: 36827869
[TBL] [Abstract][Full Text] [Related]
26. Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/β-catenin pathway.
Wang E; Wang D; Li B; Ma H; Wang C; Guan L; Zhang H; Yi L; Li S
Oncol Rep; 2017 Jan; 37(1):379-387. PubMed ID: 27878263
[TBL] [Abstract][Full Text] [Related]
27. Canonical Wnt and TGF-β/BMP signaling enhance melanocyte regeneration but suppress invasiveness, migration, and proliferation of melanoma cells.
Katkat E; Demirci Y; Heger G; Karagulle D; Papatheodorou I; Brazma A; Ozhan G
Front Cell Dev Biol; 2023; 11():1297910. PubMed ID: 38020918
[TBL] [Abstract][Full Text] [Related]
28. A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer.
Deng T; Hou Y; Lin G; Feng C; Liu K; Chen W; Wei W; Huang L; Dai X
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986805
[TBL] [Abstract][Full Text] [Related]
29. PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells.
Caraban BM; Matei E; Cozaru GC; Aşchie M; Deacu M; Enciu M; Bălţătescu GI; Chisoi A; Dobrin N; Petcu L; Gheorghe E; Hangan LT; Roșu MC; Orasanu CI; Nicolau AA
J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836455
[TBL] [Abstract][Full Text] [Related]
30. Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression.
Wang K; Dai X; Yu A; Feng C; Liu K; Huang L
J Exp Clin Cancer Res; 2022 Sep; 41(1):289. PubMed ID: 36171633
[TBL] [Abstract][Full Text] [Related]
31. Anti-cancer peptide-based therapeutic strategies in solid tumors.
Karami Fath M; Babakhaniyan K; Zokaei M; Yaghoubian A; Akbari S; Khorsandi M; Soofi A; Nabi-Afjadi M; Zalpoor H; Jalalifar F; Azargoonjahromi A; Payandeh Z; Alagheband Bahrami A
Cell Mol Biol Lett; 2022 Apr; 27(1):33. PubMed ID: 35397496
[TBL] [Abstract][Full Text] [Related]
32. The Role of Podoplanin in Skin Diseases.
Asai J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163233
[TBL] [Abstract][Full Text] [Related]
33. Roles of Podoplanin in Malignant Progression of Tumor.
Suzuki H; Kaneko MK; Kato Y
Cells; 2022 Feb; 11(3):. PubMed ID: 35159384
[TBL] [Abstract][Full Text] [Related]
34. Managing Metastatic Melanoma in 2022: A Clinical Review.
Switzer B; Puzanov I; Skitzki JJ; Hamad L; Ernstoff MS
JCO Oncol Pract; 2022 May; 18(5):335-351. PubMed ID: 35133862
[TBL] [Abstract][Full Text] [Related]
35. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.
Liu J; Xiao Q; Xiao J; Niu C; Li Y; Zhang X; Zhou Z; Shu G; Yin G
Signal Transduct Target Ther; 2022 Jan; 7(1):3. PubMed ID: 34980884
[TBL] [Abstract][Full Text] [Related]
36. Phage display and other peptide display technologies.
Jaroszewicz W; Morcinek-Orłowska J; Pierzynowska K; Gaffke L; Węgrzyn G
FEMS Microbiol Rev; 2022 Mar; 46(2):. PubMed ID: 34673942
[TBL] [Abstract][Full Text] [Related]
37. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
38. Automated affinity selection for rapid discovery of peptide binders.
Zhang G; Li C; Quartararo AJ; Loas A; Pentelute BL
Chem Sci; 2021 Aug; 12(32):10817-10824. PubMed ID: 34447564
[TBL] [Abstract][Full Text] [Related]
39. Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues.
Braun A; Anders HJ; Gudermann T; Mammadova-Bach E
Front Oncol; 2021; 11():665534. PubMed ID: 34322381
[TBL] [Abstract][Full Text] [Related]
40. Platelets, Constant and Cooperative Companions of Sessile and Disseminating Tumor Cells, Crucially Contribute to the Tumor Microenvironment.
Obermann WMJ; Brockhaus K; Eble JA
Front Cell Dev Biol; 2021; 9():674553. PubMed ID: 33937274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
